Technology evaluation: Chrysalin, OrthoLogic

Research output: Contribution to journalReview articlepeer-review

1 Scopus citations


OrthoLogic (formerly Chrysalis) is developing Chrysalin, a synthetic 23-amino acid peptide that mimics a portion of human thrombin. The compound is in phase II clinical trials for the potential treatment of diabetic foot ulcers and phase III trials for cartilage repair and bone fractures.

Original languageEnglish (US)
Pages (from-to)264-272
Number of pages9
JournalCurrent Opinion in Molecular Therapeutics
Issue number3
StatePublished - Jun 2005
Externally publishedYes

ASJC Scopus subject areas

  • Molecular Medicine
  • Molecular Biology
  • Genetics
  • Pharmacology
  • Drug Discovery
  • Genetics(clinical)


Dive into the research topics of 'Technology evaluation: Chrysalin, OrthoLogic'. Together they form a unique fingerprint.

Cite this